Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
54,911,473
-
Share change
-
+10,749,400
-
Total reported value
-
$454,020,310
-
Put/Call ratio
-
12%
-
Price per share
-
$8.27
-
Number of holders
-
125
-
Value change
-
+$61,154,299
-
Number of buys
-
77
-
Number of sells
-
57
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q2 2022
As of 30 Jun 2022,
Kezar Life Sciences Inc - COMMON-STOCK (KZR) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,911,473 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, Avidity Partners Management LP, BlackRock Inc., Bellevue Group AG, VICTORY CAPITAL MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, MARSHALL WACE, LLP, CHI Advisors LLC, and Point72 Asset Management, L.P..
This page lists
125
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.